Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Peristomal Erosion in a Man With Crohn Disease.
JAMA Dermatol
December 2024
Unit of Dermatology Clinic, Università Vita-Salute, IRCCS Ospedale San Raffaele, Milano, Italy.
Disseminated Cutaneous Mucormycosis Developing in Peristomal Pyoderma Gangrenosum.
Cureus
May 2024
Stomal Therapy Service, Royal Perth Hospital, Perth, AUS.
A patient on long-term glucocorticoid therapy for peristomal pyoderma gangrenosum (PPG) who developed mucormycosis (MM) of the wound with dissemination was presented. The importance of skin biopsy, together with clinical evaluation in patients with PPG who are resistant to conventional therapy or who develop new symptoms related to their PPG is stressed. The risk and pathogenesis of invasive fungal infections with long-term corticosteroid therapy were explored.
View Article and Find Full Text PDFLatissimus dorsi myocutaneous free flap for the laryngopharyngectomy defect.
Head Neck
August 2024
Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Article Synopsis
- Laryngopharyngectomy defects can be reconstructed using various flaps, but the latissimus dorsi myocutaneous free flap (LDMFF) is highlighted as a strong option for high-risk patients with complex defects.
- A study involving 24 patients showed a 100% flap survival rate, with some complications such as pharyngocutaneous and tracheo-esophageal fistulas, but most patients were able to sustain some oral intake.
- The findings suggest that LDMFF is effective and has manageable complications, making it a viable choice for patients, especially those who have experienced radiation treatment.
Peristomal intestinal metaplasia with response to serial electrosurgery.
JAAD Case Rep
March 2024
Department of Dermatology, University of Michigan, Ann Arbor, Michigan.
Peristomal cutaneous amebiasis causing rapidly progressive necrotic wound of a left lower quadrant end colostomy.
BMJ Case Rep
January 2024
Swedish Cancer Institute, Seattle, Washington, USA.
Cutaneous amebiasis is a rare clinical entity caused by the invasive protozoan parasite that can be readily diagnosed with skin biopsy if suspected. It presents as a rapidly progressive and destructive ulceration with necrosis. A man in his 40s with metastatic rectal cancer who underwent palliative abdominal perineal resection with end colostomy in his left lower quadrant and on systemic chemotherapy developed progressive breakdown of his peristomal skin unresponsive to antibiotics that was then diagnosed to be cutaneous amebiasis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!